Related Experiment Videos
[Muscle changes in chronic obstructive arteriopathy: a morphological, histochemical and morphometric study].
J J Burgos-Bretones1, J M Aguirre Urizar, T Bahillo del Río
1Departamento de Anatomía Patológica, Hospital de Cruces, Universidad del País Vasco, Bilbao, España.
Summary
Chronic obstructive arteriopathy in lower extremities causes similar muscle damage in diabetic and non-diabetic patients. Muscle biopsy findings help predict treatment outcomes for this condition, termed "chronic ischemic myopathy".
Area of Science:
- Neurology
- Pathology
- Vascular Medicine
Context:
- Investigating muscular alterations in patients with chronic obstructive arteriopathy of the lower extremities.
- Examining 50 patients, with 50% presenting a pure arteriosclerotic picture and the other 50% with associated diabetes.
- Comparing histopathological features between diabetic and non-diabetic patient groups.
Purpose:
- To characterize the muscular alterations associated with chronic obstructive arteriopathy in lower extremities.
- To determine if diabetes influences the histopathological muscle changes in this condition.
- To correlate clinical presentation (acute vs. chronic) with specific muscle pathologies.
Summary:
- Histopathological findings were similar in both diabetic and non-diabetic patients, indicating diabetes does not substantially alter the muscle damage.
- Myopathic changes were predominant in the tibialis anterior muscle in patients with an acute clinical course.
- Neuropathic alterations were more common in patients with a chronic clinical course.
- The study defines a characteristic histological picture of muscle lesions as "chronic ischemic myopathy".
Impact:
- Muscle biopsy provides crucial information for therapeutic strategies and prognostic predictions in chronic obstructive arteriopathy.
- Understanding these muscle lesions aids in defining and diagnosing "chronic ischemic myopathy".
- Highlights the importance of histological examination in managing lower extremity vascular disease.